eISSN: 1896-9151
ISSN: 1734-1922
Archives of Medical Science
Current issue Archive Special issues Subscription
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
2/2007
vol. 3
 
Share:
Send email
Share:
abstract:

Case report
Graves’ thyrotoxicosis in a patient with metastatic differentiated thyroid carcinoma and chronic lymphocytic leukaemia (CLL)

Jacek Makarewicz
,
Sławomir Mikosiński
,
Antoni Rutkowski
,
Zbigniew Adamczewski
,
Andrzej Lewiński

Arch Med Sci 2007; 3, 2: 179-184
Online publish date: 2007/06/29
View full text Get citation
 
Thyrotoxicosis is rare in patients with thyroid carcinoma. A case is reported of a 66-year-old woman with Graves’ disease, papillary thyroid carcinoma (PTC) with pulmonary metastases and chronic lymphocytic leukaemia (CLL). After thyroidectomy and antithyroid drug (ATD) withdrawal, thyrotoxicosis recurred. Treatment with ATD and 131I (six doses, 36.3 GBq in total) resulted in permanent hypothyroidism and significant destruction of lung metastases. The course of CLL was mild, but transient anaemia and thrombocytopenia were observed after 131I therapy. Pathomechanisms of thyrotoxicosis in patients with metastatic thyroid carcinoma, its treatment and its relation to CLL are presented.
keywords:

thyroid carcinoma, thyrotoxicosis, metastases, radioiodine therapy, chronic lymphocytic leukaemia
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.